Hospitals' Reporting Of Vre And Mrsa: Protocols And Challenges

Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) are antibiotic-resistant organisms that can cause serious infections, including surgical site infections and pneumonia. MRSA and VRE can spread in hospitals and other healthcare facilities, and people with hospitalizations or underlying medical conditions may be at greater risk for infection. In the United States, the Center for Disease Control and Prevention estimates that approximately 2 million patients acquire infections in hospitals annually, with about 90,000 of these cases resulting in death. To address this issue, hospitals employ various strategies, such as hand hygiene, contact precautions, and room cleaning, to prevent the spread of MRSA and VRE. Additionally, hospitals are responsible for reporting data related to these infections to relevant departments of health and senior services.

Hospitals report MRSA and VRE infections differently to LTCHs

MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus) are types of antibiotic-resistant bacteria that can cause serious infections. MRSA and VRE infections are commonly associated with healthcare settings, including hospitals and long-term care hospitals (LTCHs). However, it's important to note that hospitals and LTCHs may have different approaches and protocols in place for managing and reporting these infections due to varying patient populations and care contexts.

In hospitals, MRSA and VRE infections are often reported using established surveillance and screening protocols. For instance, hospitals may implement active surveillance, including culture-based surveillance for ICU patients or those admitted to high-risk units. Additionally, hospitals may use specific reporting forms or guidelines to document and share data with relevant departments or authorities, such as the Department of Health and Senior Services. Hospitals also focus on preventing the spread of these infections by employing contact precautions, such as the use of gowns and gloves, especially in emergency departments.

On the other hand, LTCHs handle MRSA and VRE infections differently. Residents in LTCHs are generally healthier than patients in hospitals, and the LTCH is their long-term residence. As a result, LTCHs may allow residents with MRSA or VRE to share rooms, but they carefully select roommates to minimize the risk of infection spread. While contact precautions are still important in LTCHs, the emphasis is on good hand hygiene for staff, residents, and visitors. This includes frequent handwashing and ensuring clean surfaces, especially in the case of VRE, which can survive on environmental surfaces for extended periods.

The reporting structures and protocols for MRSA and VRE infections may vary between hospitals and LTCHs due to the unique characteristics of their patient populations. Hospitals often deal with a higher turnover of patients, including emergency admissions, transfers, and surgical patients, which can influence the reporting dynamics and the implementation of infection control measures. In contrast, LTCHs focus on creating a safe and stable long-term living environment for their residents while managing the presence of antibiotic-resistant organisms.

Additionally, the clinical and operational considerations differ between hospitals and LTCHs. Hospitals may face challenges in efficiently managing bed assignments, patient transfers, and hospital stays, especially with the introduction of double-occupancy accommodations. On the other hand, LTCHs prioritize the well-being and comfort of their long-term residents, aiming to prevent colonization or infection while ensuring a sense of home for their residents.

Missouri mandates reporting of MRSA and VRE

In 2004, the Missouri Nosocomial Infection Control Act (also known as Senate Bill No. 1279) was passed, mandating that nosocomial methicillin-resistant staphylococcus aureus (MRSA) and nosocomial vancomycin-resistant enterococci (VRE) be included in the list of reportable diseases and/or conditions. The Act was passed in response to the growing problem of antibiotic resistance in bacteria that cause serious infections in hospitals, such as staphylococcal bacteria (or staph) and enterococci. These bacteria can cause infections such as surgical wound infections, bloodstream infections, and pneumonia, and can lead to sepsis and death if left untreated.

The Missouri Department of Health and Senior Services is responsible for receiving and managing MRSA and VRE reports. While a specific MRSA and VRE reporting form has been developed, it is not mandatory, and other formats that include all the necessary information are also acceptable. The reporting requirements include quarterly aggregate reports, which are due within ten days of the end of each quarter. The new reporting process, which utilizes a REDCap survey accessed through a single web link, aims to simplify the reporting process and improve the overall quality of the data.

The MRSA and VRE reporting process in Missouri focuses on nosocomial or healthcare-associated infections. MRSA is a type of staph bacteria that has become resistant to several antibiotics. It can spread in hospitals, healthcare facilities, and the community, and anyone can get a MRSA infection or carry MRSA. However, the risk is higher for people with hospitalizations, skin-to-skin contact, and exposure to crowded and unhygienic places. VRE refers to vancomycin-resistant enterococci, which are bacteria that are becoming resistant to standard therapies.

The Missouri HAI Program is responsible for providing hospitals and ambulatory surgical centers with a process for quarterly reporting of select HAIs, including MRSA, VRE, and CRE. The new process offers several improvements, such as reduced staff time for reporting, self-checks for accurate data reporting, and automated distribution of submission confirmation emails. By utilizing this process, facilities can easily update information and report on multiple facilities separately.

CDC estimates 2 million US hospital-acquired infections annually

The CDC estimates that each year, nearly 2 million patients in the United States contract infections in hospitals, and about 90,000 of these patients die as a result. Staphylococcal bacteria (or staph) can cause serious infections such as surgical wound infections, bloodstream infections, and pneumonia. Treatment of staph infections has become more difficult due to increasing resistance to various antibiotics, including methicillin. Enterococci are a leading cause of nosocomial bacteremia, surgical wound infection, and urinary tract infection, and they, too, are becoming resistant to standard therapies.

The CDC's annual National and State Healthcare-Associated Infections (HAI) Progress Report provides valuable insights into the prevalence and trends of HAIs. This report includes data from four healthcare settings: acute care hospitals, critical access hospitals, inpatient rehabilitation facilities, and long-term acute care hospitals. The CDC also reported increases in certain HAIs in 2021, such as a 14% increase in methicillin-resistant Staphylococcus aureus bacteremia and a 12% increase in ventilator-associated events.

To address these challenges, hospitals have implemented various reporting mechanisms for MRSA and VRE infections. While not mandatory, a MRSA VRE Reporting form serves as a guide for healthcare facilities. Hospitals may also accept other formats as long as they include all the necessary information. The Missouri Nosocomial Infection Control Act of 2004 mandates that nosocomial methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) be included in the list of reportable diseases and conditions.

The CDC's HAI Progress Report utilizes data from two complementary surveillance systems: the National Healthcare Safety Network (NHSN) and the Emerging Infections Program Healthcare-Associated Infections – Community Interface (EIP HAIC). This comprehensive approach allows for a detailed understanding of the impact of HAIs and helps guide prevention and control measures.

MRSA and VRE spread by contact with contaminated hands/surfaces

MRSA (Methicillin-Resistant Staphylococcus Aureus) and VRE (Vancomycin-Resistant Enterococcus) are serious infections that can spread in hospitals and healthcare settings. These bacteria are often resistant to common antibiotics, making them challenging to treat.

MRSA and VRE can spread through direct contact with contaminated hands or surfaces. In healthcare facilities, it is crucial for healthcare workers to maintain strict hand hygiene procedures to prevent the spread of these infections. This includes frequent handwashing with soap and water or the use of hand sanitizers, especially before and after each patient interaction.

In addition to hand hygiene, regularly disinfecting and cleaning hospital rooms, surfaces, equipment, and laundry items are essential. MRSA and VRE can survive on surfaces like furniture and towels for extended periods, ranging from hours to weeks. Therefore, proper disinfection and cleaning are critical to breaking the chain of infection.

To prevent the spread of MRSA and VRE, hospitals may implement contact precautions, which involve isolating infected or colonized patients. Visitors and healthcare workers caring for these patients may need to wear protective gear and follow strict hygiene protocols. These precautions aim to minimize the risk of transmission through direct contact or contaminated surfaces.

While the discontinuation of systematic contact precautions for MRSA and VRE patients has been studied, the results are mixed. Some research suggests that removing contact precautions did not significantly impact the rates of hospital-associated MRSA infections. However, there was a decrease in hospital-associated VRE infection rates following the stoppage of contact precautions.

Contact precautions for MRSA and VRE are not always required

Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are antibiotic-resistant bacteria that can cause serious infections in hospital settings. While contact precautions for MRSA and VRE have been common in hospitals, there is a growing body of evidence that suggests these measures may not always be necessary.

MRSA and VRE are classified as multidrug-resistant organisms (MDROs), which are resistant to commonly used antibiotics. They can cause a range of infections, including surgical site infections, bloodstream infections, pneumonia, and sepsis. Due to their resistance to antibiotics, these infections can be challenging to treat and may lead to serious complications or even death if left untreated.

Contact precautions are infection control measures that aim to prevent the spread of MDROs like MRSA and VRE. They typically involve the use of personal protective equipment (PPE), such as gowns and gloves, when caring for patients with known or suspected MDRO infections. Contact precautions may also include the use of dedicated equipment and isolation of infected patients to reduce the risk of transmission.

However, there is increasing evidence that suggests contact precautions for MRSA and VRE may not be necessary in all cases. Several studies have shown that discontinuing systematic surveillance and contact precautions for MRSA and VRE does not lead to a significant increase in infection rates. In some cases, there was even a decrease in hospital-associated VRE infection rates after contact precautions were discontinued. This suggests that other factors, such as improved antibiotics and adherence to standard precautions, may play a more significant role in preventing the spread of these organisms.

Additionally, there are several drawbacks to relying heavily on contact precautions. Firstly, they can be costly for healthcare facilities, both in terms of the expense of PPE and the time required for healthcare workers to don and doff gowns and gloves. Secondly, the use of single-use gowns and gloves can have a significant environmental impact, generating solid waste and contributing to greenhouse gas emissions. Finally, some research suggests that contact precautions may negatively impact patient care, as they can reduce the frequency of patient examinations and create barriers to effective communication between healthcare providers and patients.

In conclusion, while contact precautions have been traditionally used for MRSA and VRE, there is growing evidence to suggest that they may not always be necessary. Discontinuing contact precautions in certain settings can lead to financial savings, improved environmental sustainability, and a reduction in adverse events without increasing the risk of infection. However, it is essential to carefully consider the specific circumstances and follow evidence-based guidelines when making decisions about infection control measures.

Frequently asked questions